Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma.

These skin lesions had been evolving over 1 month and were not present at the time of diagnosis of MM. 1 Skin lesions and histological analysis of lenalidomide induced pyoderma gangrenosum: a Ulcerative skin lesion of right knee at diagnosis of pyoderma gangrenosum. b Histological picture, X400 and...

Descripción completa

Detalles Bibliográficos
Publicado en:Annals of Hematology Vol. 99; no. 2; pp. 379 - 381
Autores principales: Meunier, Mathieu, Larabi, Ayoub, Schacherer, Mathilde, Deteix, Clémence, Courby, Stéphane, Cahn, Jean Yves
Formato: letter Journal Article
Publicado: Springer Nature Feb2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141339167&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 141339167
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09395555
        1WU
      jtl: Annals of Hematology
      issn: 09395555
      maglogo: N
    pubinfo:
      dt: Feb2020
      vid: 99
      iid: 2
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        141339167
        141339167
        NLM31822948
        141339167
        10.1007/s00277-019-03846-0
        NLM31822948
        141339167
      ppf: 379
      ppct: 2
      formats:
      tig:
        atl: Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma.
      aug:
        au:
          Meunier, Mathieu
          Larabi, Ayoub
          Schacherer, Mathilde
          Deteix, Clémence
          Courby, Stéphane
          Cahn, Jean Yves
        affil: Department of Clinical Hematology, CHU Grenoble Alpes, Grenoble, France
      sug:
        subj:
          Multiple Myeloma Drug Therapy
          Pyoderma Gangrenosum Chemically Induced
          Immunologic Factors Adverse Effects
          Aged, 80 and Over
          Pyoderma Gangrenosum Drug Therapy
          Prescriptions, Drug
          Thalidomide Therapeutic Use
          Multiple Myeloma Complications
          Thalidomide Analogs and Derivatives
          Immunologic Factors Administration and Dosage
          Pyoderma Gangrenosum Therapy
          Dexamethasone Administration and Dosage
          Male
          Antineoplastic Agents, Combined Therapeutic Use
          Neutropenia Etiology
          Granulocyte Colony-Stimulating Factor Therapeutic Use
          Aged, 80 & over
          Male
      ab: These skin lesions had been evolving over 1 month and were not present at the time of diagnosis of MM. 1 Skin lesions and histological analysis of lenalidomide induced pyoderma gangrenosum: a Ulcerative skin lesion of right knee at diagnosis of pyoderma gangrenosum. b Histological picture, X400 and HES staining, showing a dense neutrophil infiltrate of the reticular dermis with leukocytoclasia. c Ulcerative skin lesion after reintroduction of lenalidomide d Healing of knee skin lesion under Pomalidomide treatment.
      pubtype: Academic Journal
      doctype:
        letter
        Journal Article
      ougenre: Unknown
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N